Sort
23,748 grants matching “melanoma”
Merkel cell polyomavirus infection and the host immune response
$207,293Jianxin You · University Of Pennsylvania · R21 · FY2019 · AR
PHASE I TRIAL TESTING MART-1 PEPTIDE IMMUNIZATION IN MALIGNANT MELANOMA
$207,266University Of California Los Angeles · M01 · FY2001 · RR
PHASE I TRIAL TESTING MART-1 PEPTIDE IMMUNIZATION IN MALIGNANT MELANOMA
$207,266University Of California Los Angeles · M01 · FY2001 · RR
Data Safety and Monitoring
$207,241Edward E Partridge · University Of Alabama At Birmingham · P30 · FY2013 · CA
Mechanisms of Macrophage Functional Switch during Skin Repair
$207,240Francesco Marangoni · University Of California-Irvine · R21 · FY2020 · AR
High-Throughput Functional Annotation of Fusion Gene Cancer Drivers
$207,235Kenneth L. Scott · Baylor College Of Medicine · R21 · FY2017 · CA
Disparate suppression of naive effector and memory T cells in tumor-bearing hosts
$207,225Jose Alejandro Guevara-Patino · University Of Chicago · R21 · FY2008 · CA
Indolecarbinol target proteins and anti-cancer signaling in human melanoma cells
$207,217Gary L Firestone · University Of California Berkeley · R01 · FY2013 · CA
CORE--Biostatistics Core D: U. of PA consortium
$207,204Phyllis A Gimotty · Wistar Institute · P01 · FY2009 · CA
Administration and Clinical Trials
$207,027Jeffrey S Weber · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2013 · CA
Development of ESiPSC approach for non-germline GEM modelling
$207,012Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Fullerene Immunoconjugates for Cancer Imaging and Treatment
$206,967Robert D Bolskar · Tda Research, Inc. · R43 · FY2008 · CA
CIRCADIAN REGULATION OF INNATE IMMUNE MECHANISMS OF VIRAL RECOGNITION
$206,875Erol Fikrig · Yale University · R21 · FY2010 · AI
Flow Cytometry Core
$206,871W Martin Kast · University Of Southern California · P30 · FY2024 · CA
Proteomics of Metastatic and Non-Metastatic Uveal Melanoma
$206,843John W Crabb · Cleveland Clinic Lerner Com-Cwru · R21 · FY2017 · CA
Hyperpolarized arginine imaging of inflammatory cells and their inhibition in GBM
$206,843Sabrina Miriam Ronen · University Of California, San Francisco · R21 · FY2016 · CA
Improving adoptive cell therapy by enhancing T cell longevity
$206,843Claudia Marcela Diaz-Montero · Cleveland Clinic Lerner Com-Cwru · R21 · FY2015 · CA
Evaluation of PAK inhibitors towards targeting adaptive mechanisms of resistance in high-risk rhabdomyosarcoma
$206,843Jason Yustein · Baylor College Of Medicine · R21 · FY2020 · CA
Online Advertising for Skin Cancer Prevention
$206,843Eleni Linos · University Of California, San Francisco · R21 · FY2017 · CA
ATYPICAL NEVI IN MELANOMA--A CASE-CONTROL STUDY
$206,813Dartmouth College · R01 · FY2001 · CA
NM23 PROTEINS AND MECHANISMS OF PDGF A CHAIN SILENCING
$206,812University Of Kentucky · R01 · FY2001 · CA
INNATE MECHANISMS REGULATING CD8+T CELL IMMUNITY
$206,760Cleveland Clinic Foundation · R01 · FY2002 · AI
Role of ADAM9 in viral RNA sensing and antiviral innate immunity
$206,742Evelyn A. Kurt-Jones · Univ Of Massachusetts Med Sch Worcester · R21 · FY2024 · AI
A quiescent G0-like cell state as a barrier to eradication oral cancer stem cells
$206,736Devraj Basu · University Of Pennsylvania · R21 · FY2015 · DE
Differentiation Therapy of Uveal Melanoma Micrometastases
$206,644Pierre L Triozzi · Wake Forest University Health Sciences · R21 · FY2015 · CA